The store will not work correctly when cookies are disabled.
5-[(2(S)-Azetidinyl)methoxy]-3-[(N-phenylcarbamoyloxy)-methyl]isoxazole
ID: ALA2165440
PubChem CID: 56949915
Max Phase: Preclinical
Molecular Formula: C15H17N3O4
Molecular Weight: 303.32
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccccc1)OCc1cc(OC[C@@H]2CCN2)on1
Standard InChI: InChI=1S/C15H17N3O4/c19-15(17-11-4-2-1-3-5-11)21-10-13-8-14(22-18-13)20-9-12-6-7-16-12/h1-5,8,12,16H,6-7,9-10H2,(H,17,19)/t12-/m0/s1
Standard InChI Key: LRAKKOBBQWUEQH-LBPRGKRZSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
20.8544 -22.3046 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.6795 -22.3046 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.9363 -21.5205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2670 -21.0337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6020 -21.5205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6462 -21.1004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8836 -21.1045 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.1687 -21.5161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4547 -21.1027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2375 -20.3048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4404 -20.5174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6529 -21.3145 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.3651 -21.5052 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.3739 -22.3301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0928 -22.7350 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.6639 -22.7503 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.1016 -23.5600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3897 -23.9766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3982 -24.8008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1176 -25.2064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8299 -24.7819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8179 -23.9591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
3 6 1 0
5 7 1 0
7 8 1 0
9 8 1 1
9 10 1 0
10 11 1 0
11 12 1 0
12 9 1 0
6 13 1 0
13 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 303.32 | Molecular Weight (Monoisotopic): 303.1219 | AlogP: 2.16 | #Rotatable Bonds: 6 |
Polar Surface Area: 85.62 | Molecular Species: BASE | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.03 | CX Basic pKa: 9.61 | CX LogP: 1.52 | CX LogD: -0.66 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.85 | Np Likeness Score: -0.94 |
References
1. Yu LF, Tückmantel W, Eaton JB, Caldarone B, Fedolak A, Hanania T, Brunner D, Lukas RJ, Kozikowski AP.. (2012) Identification of novel α4β2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity., 55 (2): [PMID:22148173] [10.1021/jm201301h] |